1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CATALYST PHARMACEUTICALS INC
Catalyst Pharmaceuticals Inc
XNAS: CPRX
31.15 -0.01 (-0.03%)
4.5M
XNAS Volume

XNAS 08 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Delisting
Catalyst Pharmaceuticals rises on Thursday as it agrees to be taken private in a $4.1 billion deal See details

Catalyst Pharma Inc - CPRX - stock price prediction, stock price target, analyst ratings from 6 analysts

Catalyst Pharma Inc has a share price target of US$ 33, revenue growth forecast of 7.2%, and profit growth estimate of 8.4% for FY26, based on top 6 analyst calls.